Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

John Pemberton

Concepts (107)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Eyelids
4
2024
29
1.440
Why?
Eyelid Neoplasms
2
2022
14
1.240
Why?
Conjunctivitis
1
2024
6
0.930
Why?
Eyelid Diseases
1
2024
12
0.900
Why?
Histiocytosis, Langerhans-Cell
1
2024
32
0.880
Why?
Intubation
2
2013
6
0.850
Why?
Dacryocystorhinostomy
2
2013
11
0.840
Why?
Nasolacrimal Duct
2
2013
11
0.840
Why?
Conjunctiva
2
2024
14
0.810
Why?
Conjunctival Neoplasms
1
2022
6
0.810
Why?
Face
2
2019
58
0.790
Why?
Blepharoptosis
2
2017
13
0.700
Why?
Xanthogranuloma, Juvenile
1
2019
4
0.670
Why?
Stents
2
2013
346
0.660
Why?
Melanoma
1
2022
281
0.630
Why?
Tenon Capsule
1
2017
1
0.580
Why?
Blepharoplasty
1
2017
9
0.580
Why?
Visual Field Tests
1
2017
14
0.580
Why?
Eye Enucleation
1
2017
10
0.580
Why?
Visual Fields
1
2017
38
0.570
Why?
Suture Techniques
1
2017
59
0.560
Why?
Orbital Neoplasms
1
2017
30
0.550
Why?
Ganglioneuroma
1
2016
4
0.540
Why?
Neurofibroma, Plexiform
1
2016
5
0.540
Why?
Choroid Neoplasms
1
2016
6
0.540
Why?
Choroid
1
2016
14
0.540
Why?
Neurofibromatosis 1
1
2016
33
0.530
Why?
Naphazoline
1
2015
1
0.500
Why?
Adrenergic alpha-Agonists
1
2015
20
0.490
Why?
Carotid Artery, Internal, Dissection
1
2015
8
0.490
Why?
Eye Injuries, Penetrating
1
2014
12
0.450
Why?
Uterine Cervical Neoplasms
1
2017
277
0.450
Why?
Carcinoma, Basal Cell
1
2014
36
0.440
Why?
Silicone Elastomers
1
2013
8
0.430
Why?
Lacrimal Duct Obstruction
1
2013
7
0.420
Why?
Monitoring, Intraoperative
1
2013
54
0.410
Why?
Adenocarcinoma
1
2017
402
0.410
Why?
Wound Healing
1
2014
203
0.410
Why?
Prosthesis Failure
1
2013
109
0.400
Why?
Skin
1
2014
416
0.360
Why?
Humans
15
2024
50201
0.330
Why?
Biopsy
2
2024
592
0.310
Why?
Skin Neoplasms
1
2014
487
0.310
Why?
Diagnosis, Differential
3
2024
1041
0.310
Why?
Middle Aged
6
2024
12356
0.300
Why?
Female
10
2024
26829
0.280
Why?
Tomography, X-Ray Computed
3
2017
1160
0.260
Why?
Male
8
2024
25572
0.240
Why?
Infant, Newborn
3
2024
2770
0.240
Why?
Chalazion
1
2024
3
0.230
Why?
Glucocorticoids
2
2024
230
0.230
Why?
Aged, 80 and over
2
2017
3158
0.170
Why?
Inflammation
1
2024
608
0.170
Why?
Facial Bones
1
2018
17
0.160
Why?
Cleft Lip
1
2018
40
0.150
Why?
Sinus Thrombosis, Intracranial
1
2018
17
0.150
Why?
Pseudotumor Cerebri
1
2018
26
0.150
Why?
Eye, Artificial
1
2017
2
0.150
Why?
Orbital Implants
1
2017
4
0.150
Why?
Adult
5
2018
13486
0.150
Why?
Preoperative Period
1
2017
47
0.140
Why?
Cleft Palate
1
2018
76
0.140
Why?
Oculomotor Muscles
1
2017
23
0.140
Why?
Subarachnoid Hemorrhage
1
2018
61
0.140
Why?
Eye Diseases
1
2017
33
0.140
Why?
Prosthesis Implantation
1
2017
46
0.140
Why?
Postoperative Period
1
2017
170
0.140
Why?
Abnormalities, Multiple
1
2018
167
0.140
Why?
Biopsy, Fine-Needle
1
2017
108
0.130
Why?
Fatal Outcome
1
2017
195
0.130
Why?
Neoplasm Metastasis
1
2017
235
0.130
Why?
Miosis
1
2015
5
0.120
Why?
Horner Syndrome
1
2015
3
0.120
Why?
Phenylephrine
1
2015
34
0.120
Why?
Ophthalmic Solutions
1
2015
20
0.120
Why?
Enoxaparin
1
2015
27
0.120
Why?
Heparin
1
2015
91
0.120
Why?
Imidazoles
1
2015
128
0.110
Why?
Warfarin
1
2015
83
0.110
Why?
Infant
2
2019
3584
0.110
Why?
Head Injuries, Closed
1
2013
8
0.110
Why?
Aged
2
2017
9505
0.110
Why?
Eye Injuries
1
2013
25
0.110
Why?
Metals
1
2013
35
0.100
Why?
Stroke
1
2018
479
0.100
Why?
Retinal Diseases
1
2013
51
0.100
Why?
Signal Processing, Computer-Assisted
1
2013
69
0.100
Why?
Device Removal
1
2013
84
0.100
Why?
Anticoagulants
1
2015
253
0.100
Why?
Follow-Up Studies
1
2017
2188
0.100
Why?
Endoscopy
1
2013
119
0.100
Why?
Magnetic Resonance Imaging
2
2018
1529
0.100
Why?
Prospective Studies
1
2017
2396
0.090
Why?
Postoperative Complications
1
2017
1027
0.090
Why?
Adolescent
1
2017
6459
0.060
Why?
Retrospective Studies
1
2017
6190
0.060
Why?
Child
1
2017
6862
0.060
Why?
Methylprednisolone
1
2018
38
0.040
Why?
Spinal Puncture
1
2018
16
0.040
Why?
Phlebography
1
2018
60
0.040
Why?
Surgical Flaps
1
2018
114
0.040
Why?
Visual Acuity
1
2018
143
0.030
Why?
Disease Progression
1
2018
821
0.030
Why?
Diagnostic Techniques, Ophthalmological
1
2013
11
0.030
Why?
Fundus Oculi
1
2013
25
0.030
Why?
Tomography, Optical Coherence
1
2013
107
0.030
Why?
Young Adult
1
2013
4052
0.010
Why?
Pemberton's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description